SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
GYRE reported Third Quarter 2026 results. The stock moved +18.7% on the print.
GYREearnings

Gyre Therapeutics, Inc. (GYRE) Q3 FY2026 earnings

November 6, 2026 · SharpeIQ Research Desk

Reported results

  • Revenues for the third quarter of 2026 were $32.9 million, compared to $32.7 million for the third quarter of 2025.
  • GAAP net loss for the third quarter of 2026 was $2.5 million, compared to GAAP net income of $1.9 million for the third quarter of 2025.
  • GAAP basic net loss per share attributable to common stockholders was $(0.04) for the third quarter of 2026, compared to GAAP basic net income per share of $0.01 for the third quarter of 2025.
  • GAAP loss from operations for the third quarter of 2026 was $1.5 million, compared to GAAP income from operations of $1.5 million for the third quarter of 2025.
  • Non-GAAP adjusted net income for the third quarter of 2026 was $354 thousand, compared to non-GAAP adjusted net income of $3,878 thousand for the third quarter of 2025.
  • Total cash, cash equivalents, short-term bank deposits, short-term investments, and long-term certificates of deposit were $98.8 million as of September 30, 2026.

Guidance

  • Full year 2026 revenue guidance affirmed at $100.5 to $111.0 million.

Notes

Prior period 2025 financial results are presented as recast in the financial statements.

Price and volatility reaction

The stock moved +18.7% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +39.7 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release4.012026-11-05
Close after release4.762026-11-06
Realised move+18.7%close to close
30d ATM IV change+39.7 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →